Where do Krystal Biotech, Inc.'s ratios come from?

Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	TTM Q1 '26	TTM Q4 '25	TTM Q3 '25	TTM Q2 '25	TTM Q1 '25
Profitability
Operating margin	42.8%+1.4pp	41.4%-1.0pp	42.4%+3.6pp	38.8%+6.2pp	32.6%+10.0pp
Net margin	53.9%+1.3pp	52.6%-0.7pp	53.3%+12.5pp	40.8%+3.7pp	37.2%+6.5pp
EBITDA margin	44.2%+1.3pp	42.9%-1.0pp	43.9%+3.6pp	40.3%+6.0pp	34.4%+9.7pp
Free cash flow margin	56.9%+8.3pp	48.5%+4.2pp	44.4%-7.3pp	51.6%+11.3pp	40.4%-2.5pp
Returns
Return on equity	19.9%+1.0pp	18.9%-0.7pp	19.7%+4.0pp	15.6%+1.7pp	13.9%+3.6pp
Return on assets	18.2%+1.1pp	17.1%-0.8pp	17.9%+3.6pp	14.3%+1.4pp	12.9%+3.3pp
Return on invested capital	24.3%+0.3pp	24%-0.8pp	24.8%+4.6pp	20.2%+3.0pp	17.2%+5.4pp
Efficiency
Asset turnover	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×	0.3×0.0×
Liquidity
Current ratio	9.5×-0.5×	10×-0.2×	10.1×+0.5×	9.7×0.0×	9.6×+2.4×
Quick ratio	9.1×-0.5×	9.6×-0.2×	9.7×+0.4×	9.3×+0.1×	9.3×+2.3×
Cash ratio	4.7×-0.2×	4.8×+0.5×	4.3×+0.2×	4.1×+0.2×	3.9×+0.5×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Debt-to-assets	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Net debt / EBITDA	-2.7×+0.2×	-2.9×-0.6×	-2.3×0.0×	-2.4×—	——
Interest coverage	6.2×+0.5×	5.7×+0.2×	5.5×+0.8×	4.8×+1.0×	3.7×—
Per Share
Book value per share	$41.85+2.8%	$40.72+6.8%	$38.14+9.0%	$34.98+6.1%	$32.96+3.6%
Valuation
Market capitalization	$7.55B+5.6%	$7.15B+39.9%	$5.11B+23.1%	$4.15B-20.1%	$5.19B+15.3%
Enterprise value	$7.06B+6.0%	$6.66B+41.0%	$4.73B+24.1%	$3.81B-22.2%	$4.89B+17.4%
Price / earnings	33.6×-1.3×	34.9×+9.2×	25.7×-2.6×	28.3×-13.6×	41.9×-8.6×
Price / sales	18.1×-0.3×	18.4×+4.7×	13.7×+2.1×	11.6×-4.0×	15.6×+0.1×
Price / book	5.9×+0.1×	5.9×+1.4×	4.5×+0.5×	4×-1.3×	5.3×+0.5×
EV / EBITDA	38.3×-1.6×	39.9×+11.1×	28.9×+2.6×	26.3×—	——
EV / sales	16.9×-0.2×	17.1×+4.5×	12.7×+2.1×	10.6×-4.1×	14.7×+0.3×
Free cash flow yield	3.1%+0.5pp	2.6%-0.6pp	3.2%-1.2pp	4.5%+1.9pp	2.6%-0.2pp
Earnings yield	3%+0.1pp	2.9%-1.0pp	3.9%+0.4pp	3.5%+1.1pp	2.4%+0.4pp
PEG ratio	0.4×+0.1×	0.3×+0.2×	0.1×—	——	——

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Krystal Biotech, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do Krystal Biotech, Inc.'s ratios come from?: Every ratio is computed from Krystal Biotech, Inc.'s SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.